已收盤 10-10 16:00:00 美东时间
-0.100
-0.57%
今日重点评级关注:Maxim Group:上调Adial Pharmaceuticals评级至"买入",目标价1.5美元;BTIG:维持Climb Bio"买入"评级,目标价从7美元升至8美元
10-01 20:13
In the last three months, 5 analysts have published ratings on Innoviva (NASDAQ...
10-01 04:01
Goldman Sachs analyst Asad Haider initiates coverage on Innoviva (NASDAQ:INVA) with a Sell rating and announces Price Target of $17.
09-30 21:06
探寻2024年最令人胆寒的生存恐怖游戏盛宴!本文带你揭秘排行榜前十的刺激之作,从经典的逃生挑战到创新的技术革新,满足你对恐惧与紧张感的极致追求。无论是硬核玩家还...
08-27 11:14
Phibro Animal Health (NASDAQ:PAHC) will release its quarterly earnings report o...
08-27 00:04
Records from August 13, 2025 indicate that Representative George Whitesides of ...
08-14 23:00
During the last three months, 4 analysts shared their evaluations of Innoviva (...
08-12 02:01
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price target from $40 to $45.
08-11 18:41
Harrow (NASDAQ:HROW) will release its quarterly earnings report on Monday, 2025...
08-08 23:05
①今日举行的业绩会中,再鼎医药管理层对部分主要产品销售情况以及下半年业绩展望做出了介绍; ②再鼎医药还就鼎优乐药物短缺问题,以及肿瘤类、精神类药物管线进展和商业化布局等问题做出了回应。
08-08 16:02